Picture of Xspray Pharma publ AB logo

XSPRAY Xspray Pharma publ AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: XSpray Pharma Gets New U.S. Patent For HyNap-Dasa

Feb 12 (Reuters) - XSpray Pharma AB (publ)  XSPRAY.ST :
    * ADDITIONAL PRODUCT PATENT IN THE US FOR HYNAP-DASA
    * ANNOUNCES THAT UNITED STATES PATENT AND TRADEMARK OFFICE
(USPTO)
HAS GRANTED XSPRAY A NEW US PATENT FOR HYNAP-DASA
    * NEW PATENT, US 10,555,937, COVERS PHARMACEUTICAL
COMPOSITION OF
COMPANY'S PRIMARY PRODUCT CANDIDATE, HYNAP-DASA

Source text for Eikon:  ID:nWkr5jLJpT 
Further company coverage:  XSPRAY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Xspray Pharma publ AB

See all news